Zhenghua Wu
4PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 09, 2025
An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti-Angiogenic Agents for Therapy: A Case Report.Li Wang, Jiaqi Wu, Ping Shao
|Dec 19, 2024
Safety of talimogene laherparepvec: a real-world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS).Yifan Hong, Kebin Cheng, Han Qu
|Jan 03, 2024
Five years of safety profile of bevacizumab: an analysis of real-world pharmacovigilance and randomized clinical trials.Li Wang, Yibo Fei, Han Qu
|Jun 17, 2015
Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.Zheqi Li, Qi Zhu, Lingyun Hu
Pageof 1
